Preliminary experience with NC100100, a new ultrasound contrast agent for intravenous injection

European Radiology

Volumn 9, Issue 3 SUPPL., 1999, Pages

  Marelli, C ^a  

^a NYCOMED IMAGING AS   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; FERRIC ION; IRON; NYCOMED; OXIDE;

ANIMAL; BLOOD FLOW VELOCITY; CLINICAL TRIAL; CORONARY ARTERY BLOOD FLOW; DOPPLER FLOWMETRY; DRUG SCREENING; ECHOCARDIOGRAPHY; ECHOGRAPHY; HEART VENTRICLE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER; LIVER CIRCULATION; METHODOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; BLOOD FLOW VELOCITY; CLINICAL TRIALS; CONTRAST MEDIA; CORONARY CIRCULATION; DRUG EVALUATION; ECHOCARDIOGRAPHY; FERRIC COMPOUNDS; HEART VENTRICLES; HUMANS; INJECTIONS, INTRAVENOUS; IRON; LIVER; LIVER CIRCULATION; OXIDES; ULTRASONOGRAPHY, DOPPLER;

EID: 0000086781     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/pl00014070     Document Type: Article

References (29)

1. Gramiak R, Shah PM (1968) Echocardiography of the aortic root. Invest Radiol 3: 356-366
2. Ophir J, Parker KJ (1989) Contrast agents in diagnostic ultrasound. Ultrasound Med Biol 15: 319-333
3. Voci P, Morris H, Marelli C (1996) The history of contrast ultrasonography and the development of echocontrast agents. In: Voci P, Caretta Q (eds) Myocardial contrast echocardiography in cardiology and cardiac surgery. CEPI, Rome, pp 13-31
4. Silverman PE, TenCate FJ, DeJong N et al (1989) Intravenous Albunex injections increase intramyocardial backscatter. Circulation 80 (Suppl. II): 369 (abstr.)
5. Villanueva FS, Glasheen WP, Sklenar J et al (1992) Successful and reproducible myocardial opacification during two-dimensional echocardiography from right heart injection of contrast. Circulation 85: 1557-1564
6. Visser CA, Kan G, David GK et al (1982) Echocardiographic-cineangiographic correlation in detecting left ventricular aneurysm: a prospective study of 422 patients. Am J Cardiol 50: 337-341
7. Freeman AP, Giles RW, Walsh WF et al. (1985) Regional left ventricular wall motion assessment: comparison of two-dimentional echocardiography and radionuclide angiography in healed myocardial infarction. Am J Cardiol 56: 8-12
8. Grayburn PA, Weiss JL, Hack TC et al. (1998) Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (Echogen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms. J Am Coll Cardiol 32: 230-236
9. Cohen JL, Cheirif J, Segar D et al. (1998) Improved left ventricular endocardial border delineation and opacification with Optison (FSO69), a new echocardiographic contrast agent. J Am Coll Cardiol 32:746-752
10. Ikonomidis I, Holmes E, Narbuvold H et al. (1998) Assessment of left ventricular wall motion and delineation of the endocardial border after intravenous injection of Infoson during dobutamine stress echocardiography. Coron Artery Dis 9:567-576
11. Nycomed Amersham, data on file
12. ACC/AHA (1997) Guidelines for the clinical application of echocardiography: executive summary. J Am Coll Cardiol 29: 862-879
13. Kaul S (1997) Myocardial contrast echocardiography: 15 years of research and development. Circulation 96: 3745-3760
14. Marwick TH, Brunken R, Meland N et al. (1998) Accuracy and feasibility of contrast echocardiography for detection of perfusion defects in routine practice: comparison with wall motion and technetium-99 m sestamibi single-photon emission tomography. J Am Coll Cardiol 32: 1260-1269
15. Kamp O, Lepper W, Vanoverschelde JL et al. (1998) Efficacy of intravenous NC100100 in first acute myocardial infarction for detection of myocardial contrast defects (abstract). Eur J Cardiol Abstr 780
16. Kamp O, Lepper W, Vanoverschelde JL et al. (in press) Intravenous myocardial contrast echocardiography for serial assessment of perfusion defects in patients with first acute myocardial infarction referred for primary PTCA
17. Lepper W, Franke A, Hoffmann R et al. (1998) Myocardial perfusion dynamics in patients with acute myocardial infarction undergoing primary PTCA as assessed by myocardial contrast echocardiography and coronary flow reserve measurement (abstract). Circulation 98 (Suppl. I):I-502
18. Ito H, Tomooka T, Sakai N et al. (1992) Lack of myocardial perfusion immediately after successful thrombolysis: a predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 85: 1699-1705
19. Agati L, Voci P, Bilotta F et al. (1994) Influence of residual perfusion within the infarct zone on the natural history of left ventricular dysfunction after acute myocardial infarction: a myocardial contrast echocardiographic study. J Am Coll Cardiol 24: 336-342
20. Needleman L, Leen E, Kyriakkopoulou K et al. (1998) NC100100: a new US contrast agent for fundamental and harmonic imaging of hepatic lesions (abstract). Radiology 209: 189
21. Cosgrove D (1996) Ultrasound contrast enhancement of tumours Clin Radiol 51 (Suppl. 1):44-49
22. Goldberg DB, Liu JB, Forsberg F (1994) Ultrasound contrast agents: a review. Ultrasound Med Biol 20: 319-333
23. Goldberg BB(1997) Ultrasound contrast agents. Dunitz, London
24. Forsberg F, Ismail MT, Merton DA et al. (1998) Ultrasound contrast imaging of normal and abnormal canine prostates. J Ultrasound Med 16:S1-S148
25. Nanda NC (1992) Echocontrast enhancers: How safe are they? Adv Echo Contrast 2: 19-24
26. Beppu S, Matsuda H, Shishido T et al. (1997) Prolonged myocardial contrast echocardiography via peripheral venous administration of QW3600 injection (Echogen): its efficacy and side effects. J Am Soc Echocardiol 10: 11-24
27. Myreng Y, Mølstad P, Ytre-Aas K et al. (in press) Safety of the transpulmonary ultrasound contrast agent NC100100: a clinical and haemodynamic evaluation in patients with suspected or proven coronary artery disease. Heart
28. Binder T, Assayag P, Baer F et al. (1999) NC100100, a new echocontrast agent for the assessment of myocardial perfusion. Safety and comparison with MIBI-SPECT in a randomized multicenter study. Clin Cardiol 22: 273-282
29. Goldberg BB, Leen E, Needleman L et al. (1998) NC100100 enhanced US imaging of the liver: a phase II double-blind, placebo-controlled, dose-finding trial in adults with focal liver disease. Radiology 209: 23 (abstr.)